Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as meropenem (active comparator)
meropenem · 1 trial · 3 indications
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Meropenem |
| 2 | ACTIVE_COMPARATOR | Imipenem-cilastatin |
| Name | Type | Description |
|---|---|---|
| Meropenem | DRUG | Intravenous |
| Imipenem-cilastatin | DRUG | Intravenous |
Inclusion Criteria: * Subjects are hospitalized males and females, aged 13 years or older, with clinical evidence of complicated skin and skin structure bacterial infection with material suitable for culture from 1 primary site of infections * Within 72 hours before enrollment or at the time of enr...
Top 20 of 28 competitors